A Florida-based firm is launching an initiative to help Israeli pharmaceutical firms enter the U.S. market.The Jacksonville-based Medical-Enterprise Development Group said it will start the Florida-Israel Biomedical Initiative next week. Its CEO and president, John Perry, cited Israel’s advanced medical technologies. “There is no place on earth with as much talent and as much innovation,” Perry said in a press release. “Our goal is to be instrumental in easing the transition for the Israeli scientist from the laboratory in Israel to U.S. commercial success.”Medical-Enterprise specializes in helping inventors and entrepreneurs, as well as larger firms in the United States and abroad, market their pharmaceutical products in the lucrative U.S. market.The Biomedical Initiative will assist Israeli companies in research and development, funding, marketing and sales.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
